Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair
Miguel A. Villalona‐Calero(University of California, Irvine), Cynthia Timmers(Cancer Genetics (United States)), Xiaobai Li(ZheJiang Academy of Agricultural Sciences), Alice P. Chen(National Institutes of Health), Konstantin Shilo(The Ohio State University Wexner Medical Center), Wenrui Duan(Dalian Medical University), John L. Marshall(Vince Lombardi Cancer Clinic), Tanios Bekaii‐Saab(WinnMed), Weiqiang Zhao(Harbin Institute of Technology), Maryam B. Lustberg(Yale Cancer Center), Judith A. Westman(Georgetown University), Jennifer M. Thurmond(Georgetown University), Larry J. Schaaf(Georgetown University), Jeffrey S. Rose(Georgetown University), Jiuping Ji(Pancreatic Cancer Action Network)
Cited by 23
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
|Nature|2011|1.3k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k